An observational study in Atherosclerosis, sponsored by Winthrop University Hospital. Completed at 1 site in United States. Open to female participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-27.
Sponsored by Winthrop University Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 468 studies in Atherosclerosis with a site in United States — 47 open to participants now, 75 under way, 17 of them phase 3. Atherosclerosis · United States.
Among the 468 studies in Atherosclerosis with a site in United States, this one is the 120th largest by enrollment of the 137 observational ones that give a count, is one of 15 that started in 2005, is one of 137 observational ones, and was the 179th registered.
1,518 studies on the registry are indexed under Atherosclerosis; 225 are open to participants now.
Browse Atherosclerosis studies →47 of the 468 studies in Atherosclerosis with a site in United States are open now. Recruiting first, the newest first:
University of Colorado, Denver · Sites in United States
Ages 55+
Verve Therapeutics, Inc. · Sites in United States
Ages 18–70
St. Jude Children's Research Hospital · Sites in United States
Ages 18+
Eli Lilly and Company · Sites in United States, Argentina, Japan and 1 more country
Ages 18+
Washington University School of Medicine · Sites in United States
Ages 18+ · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 161 Atherosclerosis studies recruiting now, 84 (52%) set no upper age limit and 33 (20%) stop at 75 or younger; 16 take children under 18; 33 take healthy volunteers.
This study: 18 Years to 60 Years · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
468 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 46 · Phase 2 84 · Phase 3 74 · Phase 4 45
First in 1973; this study’s year is marked. 15 started in 2005.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 20 is below the median of 250 across 527 observational studies indexed under Atherosclerosis.
Median enrollment 119 across the 328 interventional studies, 170 across the 137 observational. Of the 366 that completed or were terminated, 134 (37%) have results posted.
This tab as a report to print or save as PDF → With an account.
141 of 468 have an industry lead sponsor. The 10 most frequent:
Winthrop University Hospital is the lead sponsor of 42 studies on the registry; none are open to participants now.
Winthrop University Hospital has 2 studies filed under Atherosclerosis — fewer than ten, so there is no comparison to draw.
23 of the studies in Atherosclerosis with a site in United States that are under way reach primary completion within a year, 4 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05202509Phase 3NewAmsterdam PharmaCardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease | 2026-11 |
| NCT07000123Phase 3AstraZenecaA Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event | 2027-01-11 |
| NCT05132439Phase 3VA Office of Research and DevelopmentMetfOrmin BenefIts Lower Extremities With Intermittent Claudication | 2027-02-28 |
| NCT05030428Phase 3Novartis PharmaceuticalsStudy of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease | 2027-05-10 |
| NCT07121010University of PittsburghHow Animal and Plant Protein Shakes Change the Body's Nutrient and Health Responses | 2026-12 |
Add all 23 to your calendar (.ics) → With an account.
Among the 468 studies in Atherosclerosis with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to compare plaque burden in the coronary and carotid arteries 5 years after adjuvant radiotherapy in women with right sided breast cancer vs left sided breast cancer.
This study reviews case series of patients with a history of breast cancer treated with radiotherapy for at least five years. The study measures atherosclerosis by using coronary and carotid artery calcium scoring.
breast cancer patients after radiation treatment
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
10 left sided breast cancer patients 10 right sided breast cancer patients
10 left sided breast cancer 10 right sided breast cancer
Number of Participants Analyzed for Coronary Calcium Burden by AGS
Number of participants who received a coronary calcium scan.
Time frame: Year 5 Post-Initiation of Radiotherapy
| Milestone | Coronary Artery Evaluation Left Side Breast Cancer | Coronary Artery Evaluation Right Side Breast Cancer |
|---|---|---|
| Started | 9 | 11 |
| Completed | 9 | 11 |
| Not completed | 0 | 0 |
Number of participants who received a coronary calcium scan.
| Participants | Coronary Artery Evaluation Left Side Breast Cancer | Coronary Artery Evaluation Right Side Breast Cancer |
|---|---|---|
| Number of Participants Analyzed for Coronary Calcium Burden by AGS | 9 | 11 |
Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Coronary Artery Evaluation | — | 0/20 (0%) | 0/20 (0%) |
Age 60 years or younger at time of radiatiion to chest wall. All subjects had radiation at least 5 years prior to enrollment. Patients with clinical symtoms of CAD were excluded.
| Age, Categorical(Participants) | Coronary Artery Evaluation Left Side Breast Cancer | Coronary Artery Evaluation Right Side Breast Cancer | Total |
|---|---|---|---|
| <=18 years | 0 | 0 | 0 |
| Between 18 and 65 years | 9 | 11 | 20 |
| >=65 years | 0 | 0 | 0 |
| Sex: Female, Male(Participants) | Coronary Artery Evaluation Left Side Breast Cancer | Coronary Artery Evaluation Right Side Breast Cancer | Total |
|---|---|---|---|
| Female | 9 | 11 | 20 |
| Male | 0 | 0 | 0 |
The record gives a start of Aug 2005, a primary completion of May 2007 and a completion of Jan 2014. It does not say whether these dates are actual or estimated.
Results were first posted in Nov 2023, 16 years 6 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Winthrop University Hospital